Literature DB >> 17109636

Different isoforms of the Wilms' tumour protein WT1 have distinct patterns of distribution and trafficking within the nucleus.

J R Dutton1, D Lahiri, A Ward.   

Abstract

The Wilms' tumour suppressor gene WT1 encodes multiple isoforms of a transcription factor essential for correct mammalian urogenital development. Maintenance of the correct isoform ratio is critical. In humans, perturbation of this ratio causes Frasier syndrome, which is characterized by developmental defects of the kidney and urogenital tract. Different WT1 isoforms are thought to regulate transcription and participate in mRNA processing, functions reflected by a complex sub-nuclear distribution. However, the role of individual WT1 isoforms remains unclear and pathways leading to WT1 sub-nuclear localization are completely unknown. Here we use cells expressing green fluorescent protein-tagged WT1 to demonstrate that the two major WT1 isoforms occupy separate and dynamic intranuclear locations in which one isoform, WT1+KTS, preferentially associates with the nucleolus. The alternatively spliced zinc finger region is found to be critical for the initial sub-nuclear separation of WT1 isoforms, but interactions between different isoforms influence the sub-nuclear distribution of WT1. We illustrate how disruption of WT1 nuclear distribution might result in disease. This study contributes to the emerging picture of intranuclear protein trafficking.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109636      PMCID: PMC6496763          DOI: 10.1111/j.1365-2184.2006.00409.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  46 in total

1.  Assembly of the nuclear transcription and processing machinery: Cajal bodies (coiled bodies) and transcriptosomes.

Authors:  J G Gall; M Bellini; Z Wu; C Murphy
Journal:  Mol Biol Cell       Date:  1999-12       Impact factor: 4.138

Review 2.  Like attracts like: getting RNA processing together in the nucleus.

Authors:  J D Lewis; D Tollervey
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

3.  Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one.

Authors:  Michael Ladomery; John Sommerville; Sarah Woolner; Joan Slight; Nick Hastie
Journal:  J Cell Sci       Date:  2003-04-15       Impact factor: 5.285

Review 4.  The cellular organization of gene expression.

Authors:  T Misteli; D L Spector
Journal:  Curr Opin Cell Biol       Date:  1998-06       Impact factor: 8.382

5.  Dynamic relocation of transcription and splicing factors dependent upon transcriptional activity.

Authors:  C Zeng; E Kim; S L Warren; S M Berget
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

Review 6.  The genetics of Wilms' tumor--a case of disrupted development.

Authors:  N D Hastie
Journal:  Annu Rev Genet       Date:  1994       Impact factor: 16.830

7.  Paraspeckles: a novel nuclear domain.

Authors:  Archa H Fox; Yun Wah Lam; Anthony K L Leung; Carol E Lyon; Jens Andersen; Matthias Mann; Angus I Lamond
Journal:  Curr Biol       Date:  2002-01-08       Impact factor: 10.834

8.  Presence of WT1 in nuclear messenger RNP particles in the human acute myeloid leukemia cell lines HL60 and K562.

Authors:  Avril A Morrison; Michael R Ladomery
Journal:  Cancer Lett       Date:  2006-02-07       Impact factor: 8.679

9.  Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product.

Authors:  H Nakagama; G Heinrich; J Pelletier; D E Housman
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

10.  Wilms' tumour-suppressor protein isoforms have opposite effects on Igf2 expression in primary embryonic cells, independently of p53 genotype.

Authors:  A Duarte; A Caricasole; C F Graham; A Ward
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

View more
  8 in total

Review 1.  Paraspeckles.

Authors:  Archa H Fox; Angus I Lamond
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-23       Impact factor: 10.005

2.  The Wilms' tumor suppressor protein WT1 is processed by the serine protease HtrA2/Omi.

Authors:  Jörg Hartkamp; Brian Carpenter; Stefan G E Roberts
Journal:  Mol Cell       Date:  2010-01-29       Impact factor: 17.970

3.  Effects on kidney disease, fertility and development in mice inheriting a protein-truncating Denys-Drash syndrome allele (Wt1tmT396).

Authors:  Charles E Patek; David G Brownstein; Stewart Fleming; Caroline Wroe; Lorraine Rose; Anna Webb; Rachel L Berry; Paul S Devenney; Marion Walker; Oliver D K Maddocks; Nicola J Lawrence; David J Harrison; Katrina M Wood; Colin G Miles; Martin L Hooper
Journal:  Transgenic Res       Date:  2007-11-27       Impact factor: 2.788

4.  The tumor suppressor WTX shuttles to the nucleus and modulates WT1 activity.

Authors:  Miguel N Rivera; Woo Jae Kim; Julie Wells; Amanda Stone; Alexa Burger; Erik J Coffman; Jianmin Zhang; Daniel A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-04       Impact factor: 11.205

5.  The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells.

Authors:  Adina Brett; Sony Pandey; Gail Fraizer
Journal:  Mol Cancer       Date:  2013-01-08       Impact factor: 27.401

6.  Wilms' tumor protein induces an epithelial-mesenchymal hybrid differentiation state in clear cell renal cell carcinoma.

Authors:  Valerie B Sampson; Justin M David; Isabel Puig; Pratima U Patil; Antonio García de Herreros; George V Thomas; Ayyappan K Rajasekaran
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

Review 7.  Paraspeckles: nuclear bodies built on long noncoding RNA.

Authors:  Charles S Bond; Archa H Fox
Journal:  J Cell Biol       Date:  2009-08-31       Impact factor: 10.539

8.  Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancer.

Authors:  Kurtis Eisermann; Sunpreet Tandon; Anton Bazarov; Adina Brett; Gail Fraizer; Helen Piontkivska
Journal:  BMC Genomics       Date:  2008-07-16       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.